CJC 1295 W DAC (2mg)0 out of 5(0)
CJC-1295 is a synthetic analog of the Growth Hormone-Releasing Hormone. With a substitution of four amino acids, it is more resistant to proteolytic inactivation by dipeptidyl peptidase IV (DPP-IV). When combined with Drug Affinity Complex (DAC), it prolongs its half-life, as well as the duration of action in test subjects.
Studies in animals (rats, pigs, and dogs) show that serum IGF-I levels increase several days after a single administration of CJC-1295 with DAC. It sustained a dose-dependent stimulation of serum GH and IGF-I levels when injected into healthy subjects at intervals of 1-2 weeks.
It increases plasma levels of growth hormone from somatotropic cells in the pituitary gland of animal test subjects, without altering its pulsation. It doesn’t inhibit the effects of somatostatin.$97.00
TB500 (5mg)5.00 out of 5(1)
TB-500 is a synthetic fraction of the protein thymosin beta-4, which is present in virtually all human and animal cells. It consists of 43 amino acids and the gene, TMSB4X encodes it.
Thymosin beta 4 is produced in high concentrations in damaged tissues. TB-500 purports to promote endothelial cell differentiation, angiogenesis, keratinocyte migration, collagen deposition, and decreased inflammation. The healing effect of TB-500 is observed in tendons, ligaments, muscle, skin, heart, and eyes.
After an injury, thymosin beta 4 is released by platelets, macrophages, and many other cell types, to protect cells and tissues from further damage and reduce apoptosis, inflammation and microbial growth. Thymosin beta 4 binds to actin and promotes cell migration, which includes the mobilization, migration, and differentiation of stem/progenitor cells, which form new blood vessels and regenerate the tissue. Thymosin beta 4 also decreases the number of myofibroblasts in wounds, resulting in decreased scar formation and fibrosis.$97.00
BPC157 (5mg)5.00 out of 5(1)
BPC-157 stands for Body Protection Compound. It is also known as Bepecin, PL 14736, and PL10. It is a synthetic stable gastric pentadecapeptide consisting of fifteen amino acids. It is a partial sequence of BPC that is isolated from the gastric juice of humans.
It is synthetic because it doesn’t share similarities with any natural gastric peptides. It is more stable than other peptides and withstands stomach acid degradation for at least 24 hours.
More research is needed to clarify whether BPC-157 has multiple mechanisms of action. Current research in animal test subjects, suggests BPC-157 influences several growth factors usually involved in angiogenesis (the production of blood vessels) and other factors involved in regeneration following damage.
In small rats, it experimentally accelerated the healing of different wounds in tissues such as tendons, ligaments, skeletal muscle, and bone. Currently, it is in a clinical trial for treating inflammatory bowel disease.$97.00